radium Ra 223 dichloride + Magnetic Resonance Imaging + Biopsy Procedure + Biospecimen Collection + Computed Tomography + Laboratory Biomarker Analysis + Quality-of-Life Assessment for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Oct 2017: Trial registered, NCT03317392
  2. 4 Feb 2019: Trial started, NCT03317392

The trials

NCT03317392: Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis

State
Under way
Phase
Phase 1 and Phase 2
People
132 taking part
Started
4 Feb 2019
Primary completion
31 Mar 2025
Arms
Phase II Arm II (radium Ra 223 dichloride)
Results
Posted on the registry
  1. 23 Oct 2017: Trial registered
  2. 4 Feb 2019: Trial started
  3. 5 May 2026: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.